http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110093992-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1c12a2a7eaad13b30d27ce6da591256 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-81 |
filingDate | 2009-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc9c71f08d3ddf49f95c20e126f7f8f |
publicationDate | 2011-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20110093992-A |
titleOfInvention | Agricultural product extract |
abstract | The present invention is a method for producing agricultural product extract of eggplant family farm products are processed to optimize the platelet aggregation inhibitory activity of the extract. The method comprises preparing a start mix of uniform produce; Separating the soluble fraction from the produce solids; Filtering the water soluble portion; And concentrating the active substances in the filtrate. The present invention provides agricultural product extracts and glycosylated phenolic acids or phenolic esters or derivatives thereof prepared by this method; Provided are agricultural extracts comprising glycosylated flavonoids and nucleosides. The extract of the present invention is useful as a medicament for the treatment or prevention of diseases characterized by inadequate platelet aggregation. In particular, the pharmaceutical treatment or prevention of diseases characterized by inadequate platelet aggregation reduces platelet aggregation to maintain heart health; To benefit the circulation; It may be useful to normalize or benefit blood flow. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150126343-A |
priorityDate | 2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.